ACS Pharmacology & Translational ScienceBioengineeringPeer-reviewed journal article
Ex vivo model of breast cancer cell invasion in live lymph node tissue
Katerina MorgaenkoiD, Abhinav ArnejaiD, Alexander G. Ball, Audrey Marie PuteloiD, Jennifer M. MunsoniD, Melanie R. RutkowskiiD, Rebecca R. PompanoiD
Abstract
Lymph nodes (LNs) are common sites of metastatic invasion in breast cancer, often preceding spread to distant organs and serving as key indicators of clinical disease progression. However, the mechanisms of cancer cell invasion into LNs are not well understood. Existing in vivo models struggle to isolate the specific impacts of the tumor-draining lymph node (TDLN) milieu on cancer cell invasion due to the co-evolving relationship between TDLNs and the upstream tumor. To address these limitations, we used live ex vivo LN tissue slices with intact chemotactic function to model cancer cell spread within a spatially organized microenvironment. After showing that BRPKp110 breast cancer cells were chemoattracted to factors secreted by naive LN tissue in a 3D migration assay, we demonstrated that ex vivo LN slices could support cancer cell seeding, invasion, and spread. This novel approach revealed dynamic, preferential cancer cell invasion within specific anatomical regions of LNs, particularly the subcapsular sinus (SCS) and cortex, as well as chemokine-rich domains of immobilized CXCL13 and CCL1. While CXCR5 was necessary for a portion of BRPKp110 invasion into naive LNs, disruption of CXCR5/CXCL13 signaling alone was insufficient to prevent invasion towards CXCL13-rich domains. Finally, we extended this system to pre-metastatic TDLNs, where the ex vivo model predicted a lower invasion of cancer cells. The reduced invasion was not due to diminished chemokine secretion, but it correlated with elevated intranodal IL-21. In summary, this innovative ex vivo model of cancer cell spread in live LN slices provides a platform to investigate cancer invasion within the intricate tissue microenvironment, supporting time-course analysis and parallel read-outs. We anticipate that this system will enable further research into cancer-immune interactions and allow isolation of specific factors that make TDLNs resistant to cancer cell invasion, which are challenging to dissect in vivo.
- organism: human
- research focus: cell type annotation
- research focus: cell signaling & trafficking
- approach: experimental assay
- Citations
- 5
- FWCI
- 1.64
- Field percentile
- top 17%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Invadopodia-Mediated Remodeling of the Lymphatic Endothelium Drives Cancer Cell Lymphatic Dissemination and is Regulated by a CCR7-Vav2-Rac3 Signaling axis.
Sumreen Javed, Merlyn Emmanuel, … Karla C. Williams·bioRxiv·Oct 15, 2025
- An in vitro model of breast cancer metastatic niche priming
Mia Nuckhir, Sara Carla Moura Cabral, … Hannah Harrison·bioRxiv·Mar 13, 2026
- Homing Choices of Breast Cancer Cells Revealed by Tissue Specific Invasion and Extravasation Lab-on-a-chip Platforms
B. Firatligil-Yildirir, G. Bati-Ayaz, … O. Yalcin-Ozuysal·bioRxiv·Sep 25, 2020
- Ex Vivo Assay for Organ-Specific Cancer Cell Invasion
François Tyckaert, Paul Frieso Göddertz, … Francesco Baschieri·Journal of Biological EngineeringPeer-reviewed·Jun 23, 2026
- Collective invasion of the basement membrane in breast cancer driven by forces from cell volume expansion and local contractility
J. Chang, A. Saraswathibhatla, … O. Chaudhuri·bioRxiv·Jul 28, 2022
- A breast Duct-on-Chip model for emulating invasive ductal carcinoma and testing therapies
Mohammad Jouybar, Jaap M. J. den Toonder·bioRxiv·May 24, 2025